Latest Breaking News On - David fellows - Page 4 : comparemela.com

Terns Pharmaceuticals Announces Leadership Transition

Terns Pharmaceuticals Announces Leadership Transition
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Mark vignolaSenthil sundaramTerns pharmaceuticals incHead of research developmentTerns pharmaceuticals announces leadership transitionCompany nasdaqHead of research development at ternsBerry company public relationsPeritoneal cancer foundationTerns pharmaceuticalsTern chief executive officerSenior advisorErin quirkInitial public offeringDavid fellowsWestern president

Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness

Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCity ofKatya smirnyaginaAlex harrisonAshley tappNadia waheedRobert maclarenChris hollowoodAbraham scariaDrug administrationConsilium strategic communicationsNuffield laboratory of ophthalmologyLife sciencesOxford biomedical research centreBeacon therapeutics holdings limited therapeutic

Syncona : Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness

New leading gene therapy company created combining late-stage X-linked retinitis pigmentosa program from AGTC, a preclinical program spun out from the University of Oxford and a second. | June 12, 2023

United kingdomUnited statesCity ofAbraham scariaNadia waheedKatya smirnyaginaRobert maclarenAlex harrisonAshley tappChris hollowoodDrug administrationLife sciencesOxford biomedical research centreUniversity of oxfordOxford science enterprisesNuffield laboratory of ophthalmology

Beacon of Light: Retinal Gene Therapy Developer Launches with $120M

Beacon of Light: Retinal Gene Therapy Developer Launches with $120M
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United kingdomNadia waheedChris hollowoodRobert maclarenAbraham scariaElisa petrisGenetic technologies corpUniversity of oxfordJanssen pharmaceuticalsAssociation for researchBeacon therapeutics holdingOxford university innovationOxford science enterprisesApplied genetic technologiesSyncona investment managementDavid fellows

Beacon Therapeutics Raises $120M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesCity ofUnited kingdomRobert maclarenAbraham scariaOxford science enterprisesUniversity of oxfordBeacon therapeuticsUnited kingdom basedSyncona limitedOxford scienceDavid fellowsCadherin related family memberProfessor robert maclaren